These activities include inducing an immunosuppressive tumor environment by regulating immune checkpoint inhibitor expression, such PD-L1 and PD-L2 the ligands for PD-1, which can be induced in tumors by IFNs, resulting in immune evasion (80). This evidence concerns the gene PDCD1LG2 and neoplasm.